Keywords: fournier, copromote, baycol, canada, pharma, thylmer, division

Fournier To Copromote Baycol In Canada

Article | 13 January 1998

Fournier Pharma of Canada's Thylmer Division (formed in July 1997) hasnegotiated copromotion rights to Bayer's new HMG-CoA reductase inhibitor Baycol (cerivastatin) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in